UC San Diego Settles Oncologist's Retaliation Suit
A former UC San Diego oncologist receives about $36.8 million after an appeals court reduced a 2023 jury award in his whistleblower retaliation case.
San Diego Cancer News
Recent news
October 30, 2026
SOTERIA Launches Cancer Hunt Program for VeteransThe nonprofit provides free genomic profiling and biomarker interpretation to service members and veterans.
October 27, 2026
Cardiff Oncology Appoints Leila Alland as Interim CMOThe clinical-stage biotechnology firm names a new interim chief medical officer following the departure of Roger Sidhu.
October 27, 2026
Alterome to Present Cancer Trial Data in NovemberSan Diego firm will showcase new clinical and preclinical findings on its KRAS inhibitor at an upcoming symposium.
October 15, 2026
UC San Diego Health Adopts New Skin Cancer PatchThe FDA-approved CivaDerm patch offers a radiation-based treatment for patients with non-melanoma skin cancer.
October 14, 2026
AbbVie Will Launch CLL Campaign at Cabrillo National MonumentThe campaign will encourage outdoor activities for chronic lymphocytic leukemia patients with an inaugural walk on October 17, 2026.
October 6, 2026
Invivoscribe Launched LymphoTrack Flex SuiteThe San Diego-based firm released a new sequencing solution to support clonality assessment in oncology research.
September 28, 2026
Oncolytics Biotech Activated Clinical Trial SitesThe firm has opened nearly all study sites for its investigation into a treatment for metastatic colorectal cancer.
September 28, 2026
BlossomHill Therapeutics Presented Preclinical KRAS DataThe San Diego-based company shared new trial findings for its experimental pan-KRAS inhibitor, BH-501284.
September 24, 2026
Sharp Memorial Hospital Adopted Pluvicto Cancer TreatmentSan Diego medical staff now utilize a targeted radioactive therapy for men with advanced prostate cancer.